Tirzepatide vs. semaglutide: Study compares cost and health outcomes in obesity
Summary
In a US societal-perspective lifetime simulation based on SURMOUNT-5 data, tirzepatide was projected to deliver lower total costs and better health outcomes tha...
Description
In a US societal-perspective lifetime simulation based on SURMOUNT-5 data, tirzepatide was projected to deliver lower total costs and better health outcomes tha...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source